Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The "butterfly diagram": A gait marker for neurological and cerebellar impairment in people with multiple sclerosis.
Progressive multifocal leukoencephalopathy after liver transplantation can have favorable or unfavorable outcome.
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.
New insights into the management of patients with autoimmune diseases or inflammatory disorders during pregnancy.
Relationship of Obesity With Gait and Balance in People With Multiple Sclerosis.
Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.
Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity.
Increased serum concentrations of transforming growth factor-β1 (TGF-β1) in patients with Guillain-Barré syndrome.
Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.
Multiple Sclerosis.
Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens.
The Impact of MS-Related Cognitive Fatigue on Future Brain Parenchymal Loss and Relapse: A 17-Month Follow-up Study.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Human Pulmonary Surfactant Protein SP-A1 Provides Maximal Efficiency of Lung Interfacial Films.
Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis.
Activation of the niacin receptor HCA reduces demyelination and neurofilament loss, and promotes functional recovery after spinal cord injury in mice.
Virtual street-crossing performance in persons with multiple sclerosis: Feasibility and task performance characteristics.
Circulating immune cells in multiple sclerosis.
[Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.
The Effect of Dimethyl Fumarate on Cerebral Gray Matter Atrophy in Multiple Sclerosis.
Publicly Available Data Provide Evidence against NR1H3 R415Q Causing Multiple Sclerosis.
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report.
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
Imaging biomarkers in multiple Sclerosis: From image analysis to population imaging.

Pages